Geant4-based Monte Carlo simulations on GPU for medical applications - IN2P3 - Institut national de physique nucléaire et de physique des particules Access content directly
Journal Articles Physics in Medicine and Biology Year : 2013

Geant4-based Monte Carlo simulations on GPU for medical applications

Abstract

Monte Carlo simulation (MCS) plays a key role in medical applications, especially for emission tomography and radiotherapy. However MCS is also associated with long calculation times that prevent its use in routine clinical practice. Recently, graphics processing units (GPU) became in many domains a low cost alternative for the acquisition of high computational power. The objective of this work was to develop an efficient framework for the implementation of MCS on GPU architectures. Geant4 was chosen as the MCS engine given the large variety of physics processes available for targeting different medical imaging and radiotherapy applications. In addition, Geant4 is the MCS engine behind GATE which is actually the most popular medical applications' simulation platform. We propose the definition of a global strategy and associated structures for such a GPU based simulation implementation. Different photon and electron physics effects are resolved on the fly directly on GPU without any approximations with respect to Geant4. Validations have shown equivalence in the underlying photon and electron physics processes between the Geant4 and the GPU codes with a speedup factor of 80-90. More clinically realistic simulations in emission and transmission imaging led to acceleration factors of 400-800 respectively compared to corresponding GATE simulations.

Domains

Imaging
No file

Dates and versions

in2p3-00868985 , version 1 (02-10-2013)

Identifiers

Cite

J. Bert, H. Perez-Ponce, Z. El Bitar, S. Jan, Y. Boursier, et al.. Geant4-based Monte Carlo simulations on GPU for medical applications. Physics in Medicine and Biology, 2013, 58, pp.5593-5611. ⟨10.1088/0031-9155/58/16/5593⟩. ⟨in2p3-00868985⟩
59 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More